Heron Patrick J

MBX Biosciences, Inc. Common Stock ยท Director, 10% Owner

Heron Patrick J is listed in public filings as director, 10 percent owner:. This Heron Patrick J insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include MBX Biosciences, Inc. Common Stock (MBX), Mirum Pharmaceuticals, Inc. (MIRM), HilleVax, Inc. (HLVX), and Arcutis Biotherapeutics, Inc. - Common stock (ARQT). Investors use Heron Patrick J's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
MBX Biosciences, Inc. Common StockMBX$386k12.5k sharesGrant / ExerciseJun 4, 2026$386.4K12.5k shares$30.91--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Mirum Pharmaceuticals, Inc.MIRM$31M327.6k sharesOtherJan 23, 2026$15.0M159.3k shares$94.29--
Mirum Pharmaceuticals, Inc.MIRM$31M459k sharesBuyJan 23, 2026$9.0M131.4k shares$68.48--
MBX Biosciences, Inc. Common StockMBX$94M5.2M sharesBuySep 26, 2025$12.0M666.7k shares$18.00--
HilleVax, Inc.HLVX--17.2k sharesGrant / ExerciseJun 23, 2025Disclosure amount unavailable17.2k shares----
Arcutis Biotherapeutics, Inc. - Common stockARQT$359k27.4k sharesBuyJun 13, 2025$34.6K2.6k shares$13.08--
Arcutis Biotherapeutics, Inc. - Common stockARQT$278k20.6k sharesGrant / ExerciseJun 12, 2025$277.7K20.6k shares$13.50--
Arcutis Biotherapeutics, Inc. - Common stockARQT--26.4k sharesGrant / ExerciseJun 12, 2025Disclosure amount unavailable7.6k shares----
MBX Biosciences, Inc. Common StockMBX$190k16k sharesGrant / ExerciseJun 5, 2025$189.8K16k shares$11.86--
Arcutis Biotherapeutics, Inc. - Common stockARQT$333k24.8k sharesBuyJun 5, 2025$5.1K378 shares$13.41--
Arcutis Biotherapeutics, Inc. - Common stockARQT$325k24.4k sharesBuyJun 4, 2025$25.2K1.9k shares$13.32--
Mirum Pharmaceuticals, Inc.MIRM$276k6.3k sharesGrant / ExerciseMay 29, 2025$275.8K6.3k shares$44.00--
Mirum Pharmaceuticals, Inc.MIRM--5.7k sharesGrant / ExerciseMay 29, 2025Disclosure amount unavailable5.7k shares----
Mirum Pharmaceuticals, Inc.MIRM--4k sharesGrant / ExerciseMay 29, 2025Disclosure amount unavailable4k shares----
Arcutis Biotherapeutics, Inc. - Common stockARQT$308k22.5k sharesBuyMay 22, 2025$34.4K2.5k shares$13.65--
Arcutis Biotherapeutics, Inc. - Common stockARQT$273k20k sharesBuyMay 21, 2025$34.4K2.5k shares$13.66--
Arcutis Biotherapeutics, Inc. - Common stockARQT$238k17.5k sharesBuyMay 15, 2025$34.3K2.5k shares$13.62--
Arcutis Biotherapeutics, Inc. - Common stockARQT$206k15k sharesBuyMay 14, 2025$86.7K6.3k shares$13.76--
Arcutis Biotherapeutics, Inc. - Common stockARQT$119k8.7k sharesBuyMay 13, 2025$32.7K2.4k shares$13.76--
Arcutis Biotherapeutics, Inc. - Common stockARQT$86k6.3k sharesBuyMay 9, 2025$85.7K6.3k shares$13.60--
Mirum Pharmaceuticals, Inc.MIRM$7.4M168.7k sharesBuyMar 17, 2025$92321 shares$43.93--
Mirum Pharmaceuticals, Inc.MIRM$7.4M168.7k sharesBuyMar 14, 2025$23.3K528 shares$44.11--
Mirum Pharmaceuticals, Inc.MIRM$7.4M168.1k sharesBuyMar 11, 2025$42.2K963 shares$43.77--
Mirum Pharmaceuticals, Inc.MIRM$7.1M166.6k sharesBuyMar 10, 2025$32.3K758 shares$42.66--
Mirum Pharmaceuticals, Inc.MIRM$7.2M167.2k sharesBuyMar 10, 2025$25.0K577 shares$43.37--
Mirum Pharmaceuticals, Inc.MIRM$7.2M165.8k sharesBuyMar 7, 2025$25.1K580 shares$43.21--
Mirum Pharmaceuticals, Inc.MIRM$7.3M165.2k sharesBuyMar 6, 2025$58.6K1.3k shares$43.89--
Mirum Pharmaceuticals, Inc.MIRM$7.3M163.9k sharesBuyMar 5, 2025$11.9K267 shares$44.55--
Mirum Pharmaceuticals, Inc.MIRM$7.5M163.6k sharesBuyMar 4, 2025$2.6K56 shares$45.96--
Mirum Pharmaceuticals, Inc.MIRM$7.5M163.6k sharesBuyMar 4, 2025$58.3K1.3k shares$45.55--
Mirum Pharmaceuticals, Inc.MIRM$6.1M162.3k sharesBuySep 18, 2024$4.3K115 shares$37.40--
Mirum Pharmaceuticals, Inc.MIRM$6.7M162.2k sharesBuySep 6, 2024$9.6K230 shares$41.58--
Arcutis Biotherapeutics, Inc. - Common stockARQT$233k27.1k sharesGrant / ExerciseJun 14, 2024$233.5K27.1k shares$8.63--
Arcutis Biotherapeutics, Inc. - Common stockARQT--18.8k sharesGrant / ExerciseJun 14, 2024Disclosure amount unavailable10.1k shares----